ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT01208090
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
326
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
ACT-128800
DRUG:
Placebo
Sponsor
Actelion